Figure 5From: Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer Survival period of mice inoculated with A) adenocarcinoma C26; B) cervical squamous carcinoma CSC5 after injection of TKmGM-PPT. TKmGM (CMV-HSVtk-mGM-CSF-pGL3 construct); PPT - polyethylenimine-polyethylene glycol-TAT peptide copolymer; PBS – phosphate buffered saline (placebo); GCV – ganciclovir.Back to article page